Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 218

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Aging, Longevity, Inflammation, and Cancer

CARUSO, CALOGERO, LIO, DOMENICO, CAVALLONE, LUCA, FRANCESCHI, CLAUDIO·2004·Annals of the New York Academy of Sciences

Abstract

A bstract: Cancer rates increase sharply with age in both sexes, and the majority of cases of cancer occur in patients over the age of 65 years. However, the incidence and mortality for cancer level off around 85‐90 years of age, followed by a plateau, or even a decline in the last decades of life. Therefore, it seems reasonable to conclude that centenarians are endowed with a peculiar resistance to cancer. Tumor progression is a complex process that depends on interactions between tumor and host cells. One aspect of the host response, the inflammatory response, is of particular interest because it includes the release of proinflammatory cytokines, some of which may promote tumor growth and hence influence survival. Data in the literature reviewed in this paper suggest that some kind of solid tumors are affected by regulatory cytokine genotypes. In particular proinflammatory genotypes characterized by a low IL‐10 producer or a high IL‐6 producer seem to be associated with a worse clinical outcome. On the other hand, recent evidence has linked IL‐10 and IL‐6 cytokine polymorphisms to longevity. In fact, those individuals who are genetically predisposed to produce high levels of IL‐6 have a reduced capacity to reach the extreme limits of human life, whereas the high IL‐10‐producer genotype is increased among centenarians. This opposite effect of IL‐6 and IL‐10 common gene polymorphisms in cancer and longevity is intriguing. These data prompt considerations of the role that antagonistic pleiotropy plays in disease and in longevity. Inflammatory genotypes may be both friends and enemies. In fact, they are an important and necessary part of the normal host responses to pathogens, but the overproduction of inflammatory cytokines might cause immune‐inflammatory diseases and eventually death. In fact, our immune system has evolved to control pathogens, so proinflammatory responses are likely to be evolutionarily programmed to resist fatal infections, and a high IL‐6 or a low IL‐10 production is associated with increased resistance to pathogens. However, decreased level of IL‐6 or increased level of IL‐10 might better control inflammatory responses and cancer development. These conditions might result in an increased chance of long‐life survival in an environment with a reduced antigen (i.e., pathogen) load.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1196/annals.1322.001

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 218

Metadata

Authors
CARUSO, C., LIO, D., CAVALLONE, L., & FRANCESCHI, C.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2004-12
Volume
1028
Issue
1
Pages
1-13
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1998195441
Cited by
218
References
5
FWCI
4.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aging, Longevity, Inflammation, and Cancer. https://app.cochat.ai/papers/10.1196/annals.1322.001
The paper
CARUSO, C., LIO, D., CAVALLONE, L., & FRANCESCHI, C. (2004). Aging, Longevity, Inflammation, and Cancer. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1322.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.